Cytodyn Ownership

CYDY
 Stock
  

USD 0.30  0.01  3.23%   

Some institutional investors establish a significant position in otc stocks such as Cytodyn in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Cytodyn, and when they decide to sell, the otc stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Continue to Trending Equities.
  
Cytodyn retains a total of 813.04 Million outstanding shares. Cytodyn shows 8.1 percent if its outstanding shares held by insiders and 8.1 percent owned by other corporate entities . Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Cytodyn OTC Stock Ownership Analysis

The company recorded a loss per share of 0.23. Cytodyn had not issued any dividends in recent years. CytoDyn Inc. operates as a clinical-stage biotechnology company. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington. Cytodyn operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 23 people.The quote for Cytodyn is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Cytodyn please contact Nader Pourhassan at 360 980 8524 or go to https://www.cytodyn.com.

Cytodyn Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cytodyn insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cytodyn's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cytodyn insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Migliarese Antonio over two months ago via Macroaxis 
Acquisition by Migliarese Antonio of 10292 shares of Cytodyn subject to Rule 16b-3
Arman Arvin Cyrus over two months ago via Macroaxis 
Acquisition by Arman Arvin Cyrus of 1575557 shares of Cytodyn subject to Rule 16b-3
Migliarese Antonio over two months ago via Macroaxis 
Acquisition by Migliarese Antonio of 7086 shares of Cytodyn subject to Rule 16b-3
Brunke Karen J over three months ago via Macroaxis 
Acquisition by Brunke Karen J of 247111 shares of Cytodyn subject to Rule 16b-3
Migliarese Antonio over three months ago via Macroaxis 
Acquisition by Migliarese Antonio of 8313 shares of Cytodyn subject to Rule 16b-3
Migliarese Antonio over three months ago via Macroaxis 
Acquisition by Migliarese Antonio of 5208 shares of Cytodyn subject to Rule 16b-3
Migliarese Antonio over three months ago via Macroaxis 
Acquisition by Migliarese Antonio of 5614 shares of Cytodyn subject to Rule 16b-3
Migliarese Antonio over three months ago via Macroaxis 
Acquisition by Migliarese Antonio of 9824 shares of Cytodyn subject to Rule 16b-3
Migliarese Antonio over three months ago via Macroaxis 
Acquisition by Migliarese Antonio of 10292 shares of Cytodyn subject to Rule 16b-3
Migliarese Antonio over three months ago via Macroaxis 
Acquisition by Migliarese Antonio of 10807 shares of Cytodyn subject to Rule 16b-3
Migliarese Antonio over six months ago via Macroaxis 
Acquisition by Migliarese Antonio of 13509 shares of Cytodyn subject to Rule 16b-3
Gardiner Gordon A over a year ago via Macroaxis 
Acquisition by Gardiner Gordon A of 93750 shares of Cytodyn subject to Rule 16b-3

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cytodyn without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Cryptocurrency Center Now

   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module

Pair Trading with Cytodyn

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytodyn position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytodyn will appreciate offsetting losses from the drop in the long position's value.

Moving against Cytodyn

-0.59JPMJPMorgan Chase Fiscal Year End 13th of January 2023 PairCorr
-0.58TATT Inc Sell-off TrendPairCorr
The ability to find closely correlated positions to Cytodyn could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytodyn when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytodyn - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytodyn to buy it.
The correlation of Cytodyn is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytodyn moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytodyn moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytodyn can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Cytodyn information on this page should be used as a complementary analysis to other Cytodyn's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Cytodyn OTC Stock analysis

When running Cytodyn price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Please note, there is a significant difference between Cytodyn's value and its price as these two are different measures arrived at by different means. Investors typically determine Cytodyn value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytodyn's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.